What is the treatment for Shigella infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Shigella Infections

The treatment of choice for Shigella infections is antimicrobial therapy with azithromycin (1000 mg as a single dose or 500 mg daily for 3 days) or ciprofloxacin, depending on local susceptibility patterns, along with appropriate rehydration therapy. 1

Diagnostic Approach

Before initiating treatment, confirm the diagnosis through:

  • Clinical presentation (bloody diarrhea, abdominal pain, fever, tenesmus)
  • Stool examination for white blood cells
  • Stool culture (definitive diagnostic method)

Note: If microscopy is unavailable or trophozoites are not seen, patients with bloody diarrhea should be treated initially for shigellosis. 2

Antimicrobial Treatment Options

First-line options (based on local susceptibility patterns):

  • Azithromycin: 1000 mg single dose or 500 mg daily for 3 days 1
  • Ciprofloxacin: Adult dose of 500 mg twice daily for 3-5 days 2, 1
  • TMP-SMX: Adults: 160 mg TMP and 800 mg SMX twice daily for 5 days 2, 3
    • Children: 10 mg/kg/day TMP and 50 mg/kg/day SMX in two divided doses for 5 days 2, 3
  • Ampicillin: Adults: 500 mg four times daily for 5 days 2
    • Children: 100 mg/kg/day in four divided doses for 5 days 2

Alternative options (for resistant strains):

  • Nalidixic acid: 55 mg/kg/day in four divided doses for 5 days 2
  • Tetracycline: 50 mg/kg/day in four divided doses for 5 days 2

Treatment Duration

  • Immunocompetent patients: 3-5 days 1
  • Immunocompromised patients: 7-10 days 1

Special Considerations

When to Use Empiric Treatment

Empiric antimicrobial therapy is indicated in the following situations:

  • Infants < 3 months of age with suspected bacterial etiology
  • Immunocompetent patients with fever, abdominal pain, and bloody diarrhea (bacillary dysentery)
  • Recent international travelers with fever ≥38.5°C and/or signs of sepsis 2

When to Avoid Antimicrobial Treatment

  • Asymptomatic contacts of people with bloody diarrhea should not receive empiric treatment 2
  • Mass prophylaxis or prophylaxis of family members is not recommended 2

Rehydration Therapy

  • Reduced osmolarity oral rehydration solution (ORS) is recommended as first-line therapy for mild to moderate dehydration 2
  • Maintain adequate hydration and nutrition during and after the infection 1, 4

Treatment Modification

  • If no clinical response occurs within 2 days, change to another recommended antibiotic 2
  • If no improvement after an additional 2 days, refer for stool microscopy to rule out other causes like amebiasis 2
  • Antimicrobial therapy should be modified or discontinued when a clinically plausible organism is identified 2

Complications Management

  • Monitor for complications such as hemolytic uremic syndrome, reactive arthritis, and toxic megacolon 1
  • These complications require specialized management and specific rehabilitation 1

Prevention Strategies

  • Hand washing is the single most important strategy for preventing transmission 5, 4
  • Proper sanitation, safe water, and food handling practices 1
  • Isolation of hospitalized patients and implementation of enteric precautions 1

Important caveat: Due to increasing antimicrobial resistance, periodic susceptibility testing is advisable, especially in endemic and epidemic settings. 2, 1

References

Guideline

Shigelosis: Guía de Diagnóstico y Tratamiento

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An evaluation of current shigellosis treatment.

Expert opinion on pharmacotherapy, 2003

Research

Shigellosis : challenges & management issues.

The Indian journal of medical research, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.